Grading and staging systems for inflammation and fibrosis in chronic liver diseases.

PubWeight™: 1.76‹?› | Rank: Top 3%

🔗 View Article (PMID 17692984)

Published in J Hepatol on July 30, 2007

Authors

Zachary D Goodman1

Author Affiliations

1: Armed Forces Institute of Pathology, Department of Hepatic and Gastrointestinal Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA. goodman@afip.osd.mil

Articles citing this

qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients. J Hepatol (2014) 1.77

Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology (2010) 1.12

Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology (2011) 1.07

Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transplant (2014) 1.07

Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol (2010) 1.05

Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS One (2011) 1.04

Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology (2015) 0.95

Hepatoprotective versus oncogenic functions of STAT3 in liver tumorigenesis. Am J Pathol (2011) 0.91

Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am (2011) 0.91

Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurement. PLoS One (2014) 0.91

GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk. J Virol (2008) 0.90

Impact of liver fibrosis on prognosis following liver resection for hepatitis B-associated hepatocellular carcinoma. Br J Cancer (2013) 0.89

Liver stiffness assessment by tagged MRI of cardiac-induced liver motion. Magn Reson Med (2011) 0.89

Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis. Eur Radiol (2015) 0.89

Novel serum markers of fibrosis progression for the follow-up of hepatitis C virus-infected patients. Am J Pathol (2009) 0.88

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies. Hepat Med (2011) 0.83

Efficacy of interferon alpha-2b with or without ribavirin in thalassemia major patients with chronic hepatitis C virus infection: A randomized, double blind, controlled, parallel group trial. J Res Med Sci (2010) 0.81

Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy. Sci Rep (2015) 0.81

Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients. Jundishapur J Microbiol (2015) 0.80

Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol (2011) 0.80

Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases. Oxid Med Cell Longev (2016) 0.80

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement. PLoS One (2015) 0.80

Measuring liver triglyceride content in mice: non-invasive magnetic resonance methods as an alternative to histopathology. MAGMA (2013) 0.78

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy. Exp Ther Med (2015) 0.78

Assessment of liver fibrosis in chronic hepatitis B using acoustic structure quantification: quantitative morphological ultrasound. Eur Radiol (2015) 0.78

Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. Radiology (2016) 0.77

Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study. PLoS One (2016) 0.77

Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations. BMC Med Genet (2011) 0.76

IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans. JCI Insight (2016) 0.76

Recent advances in molecular magnetic resonance imaging of liver fibrosis. Biomed Res Int (2015) 0.75

Interobserver Agreement Using Histological Scoring of the Canine Liver. J Vet Intern Med (2017) 0.75

Acoustic structure quantification by using ultrasound Nakagami imaging for assessing liver fibrosis. Sci Rep (2016) 0.75

Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence. Br J Cancer (2016) 0.75

Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury. Stem Cells Transl Med (2016) 0.75

Black blood T1rho MR imaging may diagnose early stage liver fibrosis: a proof-of-principle study with rat biliary duct ligation model. Quant Imaging Med Surg (2016) 0.75

Coinfection with Helicobacter pylori and Opisthorchis viverrini Enhances the Severity of Hepatobiliary Abnormalities in Hamsters. Infect Immun (2017) 0.75

Supersonic shearwave elastography in the assessment of liver fibrosis for postoperative patients with biliary atresia. Sci Rep (2016) 0.75

Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions. World J Gastroenterol (2017) 0.75

Impact of splenic artery ligation after major hepatectomy on liver function, regeneration and viability. Sci Rep (2016) 0.75

Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B. Exp Ther Med (2016) 0.75

The Value of Circulating Nogo-B for Evaluating Hepatic Functional Reserve in Patients with Cirrhosis. Dis Markers (2015) 0.75

Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep (2017) 0.75

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation. J Korean Med Sci (2015) 0.75

Fumarylacetoacetate hydrolase knockout rabbit model for hereditary tyrosinemia type 1. J Biol Chem (2017) 0.75

Ultrasound Elastography: Review of Techniques and Clinical Applications. Theranostics (2017) 0.75

A study on the biochemical and the morphological changes in the liver in renal transplant recipients with an evidence of the HBV and the HCV infections. J Clin Diagn Res (2013) 0.75

Development of a non-invasive fibrosis test for chronic hepatitis B patients and comparison with other unpatented scores. BMC Res Notes (2013) 0.75

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases. Diseases (2016) 0.75

Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study. Infect Dis Ther (2017) 0.75

Retracted Characteristics of liver fibrosis with different etiologies using a fully quantitative fibrosis assessment tool. Braz J Med Biol Res (2017) 0.75

Effect of taurine on chronic and acute liver injury: Focus on blood and brain ammonia. Toxicol Rep (2016) 0.75

Variations in Primary Sclerosing Cholangitis Across the Age Spectrum. J Gastroenterol Hepatol (2017) 0.75

What is expected from the pathologist in the diagnosis of viral hepatitis? Virchows Arch (2011) 0.75